Annual report pursuant to Section 13 and 15(d)

Schedule of Warrant Activities (Details)

v3.22.2.2
Schedule of Warrant Activities (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Stock Warrants  
Number of Shares, Beginning | shares
Weighted Average Exercise Price, Beginning | $ / shares
Aggregate Intrinsic Value, Beginning | $
Number of Shares, Granted | shares 7,083,500
Weighted Average Exercise Price, Granted | $ / shares $ 0.05
Number of Shares, Ending | shares 7,083,500
Weighted Average Exercise Price, Ending | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years 4 years 3 months 18 days
Aggregate Intrinsic Value, Ending | $ $ 79 [1]
Number of Shares, Exercisable | shares 7,083,500
Weighted Average Exercise Price, Exercisable | $ / shares $ 0.05
Weighted Average Remaining Contractual Term in Years, Exercisable 4 years 3 months 18 days
Aggregate Intrinsic Value, Exercisable | $ $ 79 [1]
[1] The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying warrants and the closing stock price of $0.0612 for our common stock on December 31, 2021.